Early Payer Guidance Across Four Inflammatory Disease Areas

Home / Intelligence / Case Studies / Early Payer Guidance Across Four Inflammatory Disease Areas

Trinity completed an early payer guidance engagement, conducting comprehensive secondary research across four inflammatory disease areas.

Geographic Scope:

Client Situation

The client wanted to gain an in-depth understanding of four inflammatory disease areas to inform early stage decision-making.

Trinity’s Solution

Trinity conducted comprehensive secondary research in the following areas:

  • Disease background including diagnosis, prognosis, epidemiology and unmet needs
  • Current and future paradigm including lines of therapies and standard of care
  • Pipeline analysis including key therapies in development and future treatment gamechangers
  • Pricing and access landscape including pricing analysis, health technology assessment (HTA) outcomes and access status


Four disease-specific early payer guidance reports powered by comprehensive secondary research efforts into disease background, current and future treatment paradigm, pipeline analysis and pricing and access landscape.

Project Outcomes & Impact

Trinity’s comprehensive secondary research and landscape analyses helped the client to make early-stage decisions across therapeutic areas of interest from a future business development perspective.

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.